Press Releases

Poseida Therapeutics Announces Leadership Appointments

October 13, 2021

Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies

October 12, 2021

Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting

October 1, 2021

Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences

September 7, 2021

Poseida Therapeutics Presents Preliminary Results from Phase 1 Trial of P-PSMA-101 at the 6th Annual CAR-TCR Summit

August 31, 2021

Poseida Therapeutics Announces FDA Clearance of Investigational New Drug Application for P-BCMA-ALLO1, an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma

August 30, 2021

Poseida Therapeutics Reports Program Updates and Financial Results for the Second Quarter of 2021

August 12, 2021

Poseida Therapeutics Appoints Cynthia Collins to Board of Directors

July 26, 2021

Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders

June 2, 2021

Poseida Therapeutics Reports Program Updates and Financial Results for the First Quarter 2021

May 11, 2021